Home › Funds › Palo Alto Investors LP › STOK
Palo Alto Investors LP position in STOK
STOKE THERAPEUTICS INC · Health Care
Palo Alto Investors LP reported holding 84,631 shares of STOK (STOKE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.2M, representing 0.33% of its reported portfolio and ranking #37 among its reported holdings. Palo Alto Investors LP has disclosed STOK holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Palo Alto Investors LP's STOK position evolved
Palo Alto Investors LP first disclosed a stake in STOK in Q1 2024 at 125,861 shares (US$1.7M). The position peaked in Q2 2026 at 84,631 shares, worth US$2.8M. Across 11 filings, Palo Alto Investors LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 84,631 shares valued at US$2.2M. Notable position changes include a 32% trim in Q4 2025 (shares rose 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 125.86K | $1.70M | New |
| Q2 2024 | 125.86K | $1.70M | Hold |
| Q3 2024 | 125.86K | $1.55M | Hold |
| Q4 2024 | 125.86K | $1.39M | Hold |
| Q1 2025 | 125.86K | $836.98K | Hold |
| Q2 2025 | 125.86K | $1.43M | Hold |
| Q3 2025 | 105.43K | $2.48M | Reduce |
| Q4 2025 | 72.02K | $2.29M | Reduce |
| Q1 2026 | 84.63K | $2.76M | Add |
| Q2 2026 | 84.63K | $2.77M | Hold |
| Q3 2026 | 84.63K | $2.20M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About STOK and 13F data
STOK (STOKE THERAPEUTICS INC) is a Health Care company. 48 other funds we track also report a position in STOK — the largest reported positions include RTW INVESTMENTS, LP (US$146.2M), Lynx1 Capital Management LP (US$101.3M), Redmile Group, LLC (US$100.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding STOK
- RTW INVESTMENTS, LP 5.62M sh · $146.21M · Q3 2026
- Lynx1 Capital Management LP 3.90M sh · $101.30M · Q3 2026
- Redmile Group, LLC 3.87M sh · $100.59M · Q3 2026
- BVF INC/IL 3.61M sh · $93.83M · Q3 2026
- Siren, L.L.C. 2.00M sh · $51.88M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.82M sh · $47.41M · Q3 2026
- BAKER BROS. ADVISORS LP 1.31M sh · $34.16M · Q3 2026
- MPM BioImpact LLC 925.13K sh · $24.05M · Q3 2026
- Opaleye Management Inc. 700.00K sh · $22.90M · Q2 2026
- EcoR1 Capital, LLC 835.00K sh · $21.71M · Q3 2026
- Troluce Capital Advisors LLC 806.11K sh · $20.96M · Q3 2026
- Vestal Point Capital, LP 345.00K sh · $8.97M · Q3 2026
More on Palo Alto Investors LP
FAQ
How long has Palo Alto Investors LP held STOK?
Palo Alto Investors LP has disclosed STOK holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Palo Alto Investors LP's current position in STOK?
As of Q3 2026, Palo Alto Investors LP holds 84.63K shares of STOK (STOKE THERAPEUTICS INC), valued at $2.20M, representing 0.33% of its reported portfolio and ranking #37.
Has Palo Alto Investors LP been buying or selling STOK?
In the latest 13F filing (Q3 2026), Palo Alto Investors LP held unchanged its position in STOK. The position peaked in Q2 2026 at 84.63K shares.
Which other funds hold STOK?
Other major institutional holders of STOK include RTW INVESTMENTS, LP, Lynx1 Capital Management LP, Redmile Group, LLC, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.